blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2044072

EP2044072 - AMINO-IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT, ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.09.2011
Database last updated on 19.07.2024
Most recent event   Tooltip09.09.2011Application deemed to be withdrawnpublished on 12.10.2011  [2011/41]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
For all designated states
Astex Therapeutics Limited
436 Cambridge Science Park Milton Road, Cambridge
CB4 0QA / GB
[2009/15]
Inventor(s)01 / BERG, Stefan
AstraZeneca R & D Södertälje
151 85 Södertälje / SE
02 / HOLENZ, Jörg
AstraZeneca R & D Södertälje
151 85 Södertälje / SE
03 / HÖGDIN, Katharina
AstraZeneca R & D Södertälje
151 85 Södertälje / SE
04 / KOLMODIN, Karin
AstraZeneca R & D Södertälje
151 85 Södertälje / SE
05 / PLOBECK, Niklas
AstraZeneca R & D Södertälje
151 85 Södertälje / SE
06 / ROTTICCI, Didier
AstraZeneca R & D Södertälje
151 85 Södertälje / SE
07 / SEHGELMEBLE, Fernando
AstraZeneca R & D Södertälje
151 85 Södertälje / SE
08 / EK, Maria
AstraZeneca R & D Södertälje
151 85 Södertälje / SE
 [2009/15]
Application number, filing date07748237.012.06.2007
[2009/15]
WO2007SE00574
Priority number, dateUS20060813539P14.06.2006         Original published format: US 813539 P
US20070896984P26.03.2007         Original published format: US 896984 P
[2009/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007145571
Date:21.12.2007
Language:EN
[2007/51]
Type: A1 Application with search report 
No.:EP2044072
Date:08.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 21.12.2007 takes the place of the publication of the European patent application.
[2009/15]
Search report(s)International search report - published on:SE21.12.2007
ClassificationIPC:C07D487/04, A61K31/519, A61P25/28
[2009/15]
CPC:
C07D487/04 (EP,KR,US); A61K31/519 (KR); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P9/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/15]
Extension statesAL14.01.2009
BA14.01.2009
HR14.01.2009
MK14.01.2009
RS14.01.2009
TitleGerman:AMINOIMIDAZOLONE UND IHRE VERWENDUNG ALS MEDIKAMENTE ZUR BEHANDLUNG VON KOGNITIVEN STÖRUNGEN, ALZHEIMER-KRANKHEIT, NEURODEGENERATION UND DEMENZ[2009/15]
English:AMINO-IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT, ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA[2009/15]
French:AMINOIMIDAZOLONES ET LEUR USAGE COMME MEDICAMENT POUR TRAITER DES DOMMAGES COGNITIFS, LA MALADIE D'ALZHEIMER, LA NEURODEGENERATION ET LA DEMENCE[2009/15]
Entry into regional phase14.01.2009National basic fee paid 
14.01.2009Search fee paid 
14.01.2009Designation fee(s) paid 
14.01.2009Examination fee paid 
Examination procedure17.12.2008Amendment by applicant (claims and/or description)
14.01.2009Examination requested  [2009/15]
04.01.2011Application deemed to be withdrawn, date of legal effect  [2011/41]
04.03.2011Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2011/41]
Fees paidRenewal fee
30.06.2009Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.06.201004   M06   Not yet paid
30.06.201105   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US2005282826  (MALAMAS MICHAEL S [US], et al);
 [XP]WO2006076284  (WYETH CORP [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.